Trimodality therapy for stage IIIA non-small cell lung cancer: Benchmarking multi-disciplinary team decision-making and function

Highlights • We evaluated multidisciplinary decision making in locally-advanced NSCLC. • Trimodality therapy is a valuable treatment option in carefully selected patients. • Mortality and overall survival support decision-making by our multidisciplinary board. • The role of trimodality therapy in cN...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2014-08, Vol.85 (2), p.218-223
Hauptverfasser:	Dickhoff, C, Hartemink, K.J, van de Ven, P.M, van Reij, E.J.F, Senan, S, Paul, M.A, Smit, E.F, Dahele, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Benchmarking Biological and medical sciences Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - therapy Chemoradiotherapy Combined Modality Therapy Female Follow-Up Studies Hematology, Oncology and Palliative Medicine Humans Interdisciplinary Communication Locally-advanced Lung Neoplasms - diagnosis Lung Neoplasms - mortality Lung Neoplasms - pathology Lung Neoplasms - therapy Male Medical sciences Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Neoplasm Staging Non small-cell lung cancer Outcome Patient Care Team Pneumology Pulmonary/Respiratory Surgery Treatment Outcome Trimodality Tumors Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • We evaluated multidisciplinary decision making in locally-advanced NSCLC. • Trimodality therapy is a valuable treatment option in carefully selected patients. • Mortality and overall survival support decision-making by our multidisciplinary board. • The role of trimodality therapy in cN2 and large tumors merits further evaluation.
ISSN:	0169-5002 1872-8332
DOI:	10.1016/j.lungcan.2014.06.005